SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for MYRIAD GENETICS INC (MYGN) (CIK 0000899923) (MYGN) — Mar 30, 2012

MYRIAD GENETICS INC (MYGN) (CIK 0000899923)
Date: March 30, 2012 · CIK: 0000899923 · Accession: 0000000000-12-016346

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 000-26642

Date
March 30, 2012
Author
/s/ Joel Parker
Form
UPLOAD
Company
MYRIAD GENETICS INC (MYGN) (CIK 0000899923)

Letter

March 30, 2012 Via E-mail Mr. James S. Evans Chief Financial Officer Myriad Genetics, Inc. 320 Wakara Way Salt Lake City, UT 84108 Re: Myriad Genetics, Inc. Form 10-K for the Fiscal Year Ended June 30, 2011 Filed August 15, 2011 File No. 000-26642

Dear Mr. Evans: We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or the filings and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi lings to be certain that the filings include the information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,
/s/ Joel Parker
Joel Parker Accounting Branch Chief

Show Raw Text
March 30, 2012
 Via E-mail

Mr. James S. Evans Chief Financial Officer  Myriad Genetics, Inc.  320 Wakara Way  Salt Lake City, UT 84108
Re:  Myriad Genetics, Inc.
Form 10-K for the Fiscal Year Ended June 30, 2011 Filed August 15, 2011
  File No.  000-26642

Dear Mr. Evans:
We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or the filings and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi lings to be certain that the filings include the
information the Securities Exchange Act of 1934 and all applicable rules require.

Sincerely,

 /s/ Joel Parker
Joel Parker Accounting Branch Chief